Invention Grant
US08426437B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors
有权
吡咯并喹啉衍生物及其作为蛋白激酶抑制剂的用途
- Patent Title: Pyrroloquinoline derivatives and their use as protein kinases inhibitors
- Patent Title (中): 吡咯并喹啉衍生物及其作为蛋白激酶抑制剂的用途
-
Application No.: US11988142Application Date: 2006-06-30
-
Publication No.: US08426437B2Publication Date: 2013-04-23
- Inventor: Hugues Bienayme , Antoine Dumoulin , Serge Grisoni , Bachir Kaloun El , Stephane Poigny , Remi Rabot , Rachid Rahali , Eric Tam , Pascaline Klein , Karim Bedjeguelal , Houcine Rahali
- Applicant: Hugues Bienayme , Antoine Dumoulin , Serge Grisoni , Bachir Kaloun El , Stephane Poigny , Remi Rabot , Rachid Rahali , Eric Tam , Pascaline Klein , Karim Bedjeguelal , Houcine Rahali
- Applicant Address: FR Boulogne-Billancourt
- Assignee: Pierre Fabre Medicament
- Current Assignee: Pierre Fabre Medicament
- Current Assignee Address: FR Boulogne-Billancourt
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: FR0507009 20050701
- International Application: PCT/EP2006/063768 WO 20060630
- International Announcement: WO2007/003611 WO 20070111
- Main IPC: A61K31/437
- IPC: A61K31/437 ; C07D487/04 ; C07D471/04
Abstract:
The present invention relates to inhibitors of protein kinases of formula I: which can be used in the treatment of various diseases, notably cancer, inflammation or disorders of the central nervous system. It also relates to pharmaceutical compositions containing the compounds according to the invention and their use in therapy.
Public/Granted literature
- US20090042876A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors Public/Granted day:2009-02-12
Information query
IPC分类:
